HDII (Hypertension Diagnostics) EBIT per Share: $0.00 (TTM As of Sep. 2019)


What is Hypertension Diagnostics EBIT per Share?

Hypertension Diagnostics HDII -99.00% EBIT per Share is $0.00 as of Sep. 2019.

Hypertension Diagnostics's EBIT per Share for the three months ended in Sep. 2019 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hypertension Diagnostics's EBIT per Share or its related term are showing as below:

HDII's 3-Year EBIT Growth Rate is not ranked *
in the Diversified Financial Services industry.
Industry Median: 15.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Hypertension Diagnostics's EBIT for the three months ended in Sep. 2019 was $0.00 Mil.

Hypertension Diagnostics  (OTCPK:HDII) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Hypertension Diagnostics EBIT per Share Related Terms

Hypertension Diagnostics EBIT per Share Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics EBIT per Share Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.03 -0.01 -0.00 0.00

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hypertension Diagnostics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hypertension Diagnostics's EBIT per Share for the fiscal year that ended in Dec. 2018 is calculated as

EBIT per Share(A: Dec. 2018 )
=EBIT/Shares Outstanding (Diluted Average)
=0.036/52.389
=0.00

Hypertension Diagnostics's EBIT per Share for the quarter that ended in Sep. 2019 is calculated as

EBIT per Share(Q: Sep. 2019 )
=EBIT/Shares Outstanding (Diluted Average)
=0/52.389
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $0.00 mean?
Hypertension Diagnostics (HDII) has a EBIT per Share of $0.00 as of Sep. 2019. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' EBIT per Share too high?
Hypertension Diagnostics' current EBIT per Share is $0.00.
How does Hypertension Diagnostics' EBIT per Share compare to ESTRF and OCLN?
Hypertension Diagnostics' EBIT per Share of $0.00 can be compared against companies in the Diversified Financial Services industry. The industry median EBIT per Share is 15.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Diversified Financial Services company?
The median EBIT per Share among Diversified Financial Services companies is 15.30, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hypertension Diagnostics and its competitors. For the Diversified Financial Services industry, the median EBIT per Share is 15.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypertension Diagnostics's current EBIT per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current EBIT per Share of $0.00. The current EBIT per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current EBIT per Share is $0.00 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.